BREAKING NEWS

Boost high-risk people with Omicron-tailored shots first - EU officials

EU officials on Tuesday recommended that the two Omicron- tailored vaccines recently endorsed by the European Medicines Agency (EMA) be first deployed in high-risk individuals.

Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy